ERBB2 and breast cancer: The higher concentrations of CA 15-3 (23.85 U/mL) and VEGF (145.03 pg/mL) were also observed in the group of patients with luminal B HER2-positive BC than in the healthy controls (p = 0.006; p = 0.001).